Larvol Delta - Tris-Pharma-Presents-New-Clinical-Data-Demonstrating-Robust-Safety-and-Efcacy-of-Investigational-FirstinClass-Therapy-Cebranopadol-for-Treatment-of-Pain

cebranopadol (TRN-228) - Tris Pharma

https://www.businesswire.com/news/home/20240805194778/en/Tris-Pharma-Presents-New-Clinical-Data-Demonstrating-Robust-Safety-and-Efficacy-of-Investigational-First-in-Class-Therapy-Cebranopadol-for-Treatment-of-Pain

Aug 6, 2024

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next